ARTV
NASDAQ · Biotechnology
Artiva Biotherapeutics Inc
$7.05
+0.06 (+0.86%)
Open$6.91
Previous Close$6.99
Day High$7.19
Day Low$6.75
52W High$14.53
52W Low$2.52
Volume—
Avg Volume622.6K
Market Cap341.74M
P/E Ratio—
EPS$-3.43
SectorBiotechnology
Analyst Ratings
Strong Buy
12 analysts
Price Target
+15.5% upside
Current
$7.05
$7.05
Target
$8.14
$8.14
$7.28
$8.14 avg
$10.62
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 567.1K | 1.13M | 14.43M |
| Net Income | -147,662,558 | -265,527,077 | -2,421,627 |
| Profit Margin | -26,045.0% | -24,742.8% | -16.8% |
| EBITDA | -154,251,730 | -292,785,501 | -2,990,686 |
| Free Cash Flow | — | — | -1,604,262 |
| Rev Growth | -50.0% | -50.0% | +14.0% |
| Debt/Equity | 0.00 | 0.00 | 0.31 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $266.28 | +0.73% | 74.3 | 468.50B |
| AMGN | Amgen Inc | $418.13 | +0.85% | 25.1 | 219.78B |
| GILD | Gilead Sciences Inc | $152.21 | +0.85% | — | 185.02B |
| VRTX | Vertex Pharmaceuticals Inc | $527.67 | +0.28% | 30.5 | 134.17B |
| REGN | Regeneron Pharmaceuticals | $752.25 | -4.54% | 18.8 | 81.31B |
| ALNY | Alnylam Pharmaceuticals Inc | $255.36 | -0.23% | 41.4 | 33.44B |